Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
37.07
+0.91 (2.52%)
Mar 30, 2026, 11:54 AM EDT - Market open

Sionna Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
1,6681,840---
Market Cap Growth
121.15%----
Enterprise Value
1,3261,611000
Last Close Price
37.0741.14---
PE Ratio
--21.88---
PB Ratio
5.276.00---
P/TBV Ratio
4.825.36---
P/FCF Ratio
--27.60---
P/OCF Ratio
--27.75---
EV/EBITDA Ratio
--18.24---
EV/EBIT Ratio
--18.11---
EV/FCF Ratio
--24.17---
Debt / Equity Ratio
0.020.020.050.290
Debt / EBITDA Ratio
-0.10-0.10-0.14-0.21-
Debt / FCF Ratio
-0.13-0.13-0.18-0.23-
Net Debt / Equity Ratio
-0.74-0.740.840.241.18
Net Debt / EBITDA Ratio
2.572.571.970.562.00
Net Debt / FCF Ratio
3.413.412.610.632.18
Quick Ratio
20.1420.1414.164.7910.01
Current Ratio
20.6120.6114.494.8810.16
Return on Equity (ROE)
-31.79%-31.79%-61.44%-83.45%-50.86%
Return on Assets (ROA)
-34.78%-34.78%-59.37%-72.26%-47.35%
Return on Invested Capital (ROIC)
-164.03%-164.03%-403.40%-3840.75%1184.09%
Return on Capital Employed (ROCE)
-36.35%-36.35%-64.36%-81.83%-52.29%
Earnings Yield
-4.63%-4.57%---
FCF Yield
-4.10%-3.62%---
Buyback Yield / Dilution
-935.60%-935.60%-31.56%99.89%-
Total Shareholder Return
-935.60%-935.60%-31.56%99.89%-
Updated Mar 2, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q